Navigation Links
U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
Date:4/8/2008

- ORENCIA is a First-in-Class Biologic Treatment Option Now Available for

Use in Pediatric Patients with JIA(1,2) -

PRINCETON, N.J., April 8, 2008 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved ORENCIA(R) (abatacept) for reducing signs and symptoms in pediatric patients six years and older with moderately to severely active polyarticular juvenile idiopathic arthritis (JIA). ORENCIA may be used as monotherapy or concomitantly with methotrexate (MTX). ORENCIA should not be administered concomitantly with tumor necrosis factor (TNF) antagonists and is not recommended for use concomitantly with other biologic rheumatoid arthritis (RA) therapy, such as anakinra. This new indication for ORENCIA provides significant evidence of its durable efficacy and long-term safety in pediatric patients, including those initiating biologic therapy for the first time. The safety and efficacy of ORENCIA in JIA were assessed in a three-part study through one year. The approval of ORENCIA in JIA represents the ongoing commitment of Bristol-Myers Squibb in this therapeutic area.

"In a JIA clinical trial, ORENCIA provided meaningful and sustained improvements in this patient population across three major sub-types of JIA through one year," said Edward H. Giannini, M.Sc., Dr.P.H., Professor of Pediatrics, Division of Rheumatology, Cincinnati Children's Hospital Medical Center, OH.

The approval is based on the AWAKEN (Abatacept Withdrawal study to Assess efficacy and safety in Key Endpoints in juvenile idiopathic arthritis Not responding to current treatment) trial, which evaluated the efficacy and safety of ORENCIA(R) (abatacept) in
'/>"/>

SOURCE Bristol-Myers Squibb Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
2. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
3. Northwestern Offers Clinical Research and Regulatory Administration Graduate Certificate Program
4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
5. Biological Psychiatry Publishes Study Showing VYVANSE Demonstrated Significant Efficacy for Treatment of ADHD for up to 12 Hours After Administration
6. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
7. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
8. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
9. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
10. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
11. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... York , August 4, 2015 ... titled " Non-invasive Prenatal Testing (NIPT) Market (BambniTest, Harmony, ... Others) - Global Industry Analysis, Size, Volume, Share, Growth, ... According to a new market report published by Transparency ... Industry Analysis, Size, Volume, Share, Growth, Trends and Forecast ...
(Date:8/4/2015)... Aug. 4, 2015 BioElectronics Corporation (OTC ... Musculoskeletal Pain Therapy medical devices, announced today that ... ActiPatch 7-day trial device has been published in ... Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 ... submitted an assessment.  Chronic pain ...
(Date:8/4/2015)... DUBLIN , Aug. 4, 2015 Research ... of the "Alcohol Ethoxylate Market by Application (Household ... Geographies Global Market Trends, Forecasts to 2019" report ... of alcohol ethoxylate was valued at $5,124.9 million in ... of about 3.5% from 2014 to 2019. The data ...
Breaking Medicine Technology:Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 2Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 3Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 4Non-invasive Prenatal Testing (NIPT) Market Expected to Reach USD 2.38 Billion in 2022: Transparency Market Research 5BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 2Global Alcohol Ethoxylate Market 2015 - Market Trends, Forecasts to 2019 for the $5.1 Billion Industry 3
... SALT LAKE CITY, May 11, 2011 Dynatronics Corporation (Nasdaq: ... its quarter ended March 31, 2011 during the morning of ... a conference call for investors later that day at 1:00 ... interested in participating should call (800) 926-7510 and use access ...
... 11, 2011 BioSpecifics Technologies Corp. (NASDAQ: ... collagenase-based products, today announced that BioSpecifics, President, Tom Wegman, ... Annual Equity Conference on Tuesday, May 17th at 9:30am ... A live webcast of the presentation can ...
Cached Medicine Technology:
(Date:8/5/2015)... (PRWEB) , ... August 05, 2015 , ... ... leading stevia brand, SweetLeaf®, was honored as one of this year’s 50 Most ... trailblazers and innovators in Arizona business. Carol May’s long-standing dedication to the well-being ...
(Date:8/4/2015)... ... August 05, 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed ... update, MillionaireMatch.com has been ranked as the best dating service in the segment. , ... life companion. It is essential that people find the right dating platform so that ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... How cool ... share what inspires you via geolocation? The new "Now" feature will soon allow you ... will be able to inspire each other using the now feature. , Users will ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Sponsored by ... Foundation AZ, which is a 501(c) nonprofit organization. , According to the New ... tournament. Sponsors will get a package that includes a complimentary foursome for the tournament, ...
(Date:8/4/2015)... ... August 04, 2015 , ... assistPoint Partners, LLC ... consolidate oncology patient assistance programs. Through a secure web portal, assistPoint connects Life ... an enterprise level, cloud-based application and workflow solution. This provides cancer center patient ...
Breaking Medicine News(10 mins):Health News:Carol May Named One of the Most Influential Woman in Arizona 2Health News:Carol May Named One of the Most Influential Woman in Arizona 3Health News:Carol May Named One of the Most Influential Woman in Arizona 4Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:Ahhaa App Soon to Release the "Now" Feature 2Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:assistPoint.com Web Site Launched 2
... relatively novel technique for pain relief has been developed ... which holds a lot of promise// in alleviating extreme ... Para Vertebral Neurolytic block, which is a concoction of ... when injected into the para vertebral space. This works ...
... a test that they say can detect the deadly ... exist, but they are expensive// and time-consuming. Time is ... 24 hours. ,Professor Peter Seeberger and his ... antibodies against the anthrax surface molecule. They then attached ...
... Asia and Pacific will be promoted by the Asian Development Bank ... ADB report released on Friday. ,The ADB will conduct ... grant of $1 million, to address a broad range of growing ... Asia's energy consumption taking a heavy toll on the environment, ADB ...
... giants, Coke and Pepsi have challenged on Friday the ban ... drinks// , in separate petitions before the Kerala High Court. ... states had imposed a limited restriction on the sales of ... New Delhi, The Centre for Science and Environment (CSE), which ...
... US has ruled on Thursday that tobacco companies could no ... judge though did rule in their favour by giving the ... of any costly quitting programmes. , ,US District ... industry had 'marketed and sold their lethal product with zeal, ...
... of incomplete vaccination on the poultry flocks could be the ... ,Scientists at the Universities of Edinburgh and Warwick have ... of spreading of the deadly strains of bird flu like ... The researchers have explained in their study that has been ...
Cached Medicine News:Health News:Complete Vaccination Of Poultry Flock Essential to Check The Spread Of Avian Flu 2
... Topical, Bactericide, Microbicide for professional degerming, ... in skin disinfectants combining quaternary and ... synergistic blend of emollients and surfactants. ... gram-positive organisms tested in 30 seconds. ...
Aplicare's disposable 1-ounce pouches are designed for individual application and are ideal for reducing waste. They are used in nursing homes, home healthcare settings, blood banks, laboratories, em...
... multi-purpose topical solution is for ... Prep Spray is labeled for ... of cross contamination. The controlled ... method to the final step ...
... two and four ounce bottles ... the needs of procedural kit ... itself has been custom molded ... the cap perfectly. This product ...
Medicine Products: